Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Pindovic, Bozidar (58514599800)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model
    (2024)
    Rakic, Dejana (57723077000)
    ;
    Jakovljevic, Vladimir (56425747600)
    ;
    Zivkovic, Vladimir (55352337400)
    ;
    Jakovljevic Uzelac, Jovana (57210212812)
    ;
    Jovic, Nikola (57189444092)
    ;
    Muric, Maja (59002523500)
    ;
    Pindovic, Bozidar (58514599800)
    ;
    Dimitrijevic, Aleksandra (14008428400)
    ;
    Arsenijevic, Petar (55444435300)
    ;
    Rakic, Jovan (58396770100)
    ;
    Mitrovic, Slobodanka (36017336100)
    ;
    Vulovic, Tatjana (57212272585)
    ;
    Joksimovic Jovic, Jovana (57723391500)
    Polycystic ovary syndrome (PCOS) is the most common complex endocrinological condition of women that is associated with infertility and metabolic disorders during the reproductive period. Recently, a great deal of research has focused on the etiopathogenesis of this disorder and the modulation of therapeutic approaches. There are still many controversies in the choice of therapy, and metformin is one of the most commonly used agents in the treatment of PCOS. Considering the link between metabolic disorders and PCOS, glycemic status is crucial in these patients, and sodium-glucose cotransporter type 2 inhibitors (SGLT2is) represent a potentially promising new therapeutic approach. These drugs have been shown to improve glucose metabolism, reduce adipose tissue, decrease oxidative stress, and protect the cardiovascular system. These data prompted us to investigate the effects of empagliflozin (EMPA) in a PCOS rat model and compare them with the effects of metformin. We confirmed that EMPA positively affects somatometric parameters, glucose and lipid metabolism, and the levels of sex hormones, as well as reduces oxidative stress and improves ovarian function and morphology. Administration of EMPA at doses of 5 mg/kg, 15 mg/kg, and 45 mg/kg during a 4-week treatment period improved, as induced by estradiol valerate and a high-fat diet, the metabolic and reproductive statuses in a PCOS rat model. The best effects, which were comparable to the effects of metformin, were achieved in groups receiving the middle and highest applied doses of EMPA. These results may prompt further clinical research on the use of EMPA in patients with PCOS. © 2024 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The Enhanced Effects of Swimming and Running Preconditioning in an Experimental Model of Myocardial Ischemia/Reperfusion Injury
    (2023)
    Glisic, Milos (57218213952)
    ;
    Nikolic Turnic, Tamara (56425849500)
    ;
    Zivkovic, Vladimir (55352337400)
    ;
    Pindovic, Bozidar (58514599800)
    ;
    Chichkova, Natalia Vasilievna (36865480100)
    ;
    Fisenko, Vladimir Petrovich (7005928425)
    ;
    Nikolic, Marina (57201737753)
    ;
    Stijak, Lazar (23487084600)
    ;
    Yurievna, Lemina Elena (58727984000)
    ;
    Veselinovic, Mirjana (54418120000)
    ;
    Jovicic, Milena (57193556972)
    ;
    Mihajlovic, Katarina (55102879800)
    ;
    Bolevich, Sergey (6603144931)
    ;
    Jakovljevic, Vladimir (56425747600)
    Background and Objectives: This study was conducted to examine the influence of different swimming and running protocols as forms of physiological preconditioning on an isolated rat heart’s ischemia/reperfusion injury. Materials and Methods: This study was conducted on 60 male Wistar albino rats (6 weeks old, bw: 200 ± 20 g), divided into: CTRL group—a sedentary control group; sAeT—a group that underwent aerobic swimming conditioning using a swimming protocol for 8 weeks; sAnT—a group that underwent anaerobic swimming conditioning; rAeT—a group that underwent aerobic running conditioning; and rAnT—a group that underwent anaerobic running conditioning. After the preconditioning protocols, ex vivo estimating of myocardial function according to the Langendorff technique was performed. Results: The anaerobic running training decreased heart rate and the anaerobic swimming training reduced coronary flow, demonstrating the difference in the physiological heart response of aerobic/anaerobic physical training (p < 0.05). Heart rate was significantly reduced in both training swimming groups after a period of ischemia (p < 0.05). On the other hand, the anaerobic running protocol induced a significantly decreased heart rate in comparison with the aerobic running group and the sedentary group (p < 0.05). Conclusions: The data from this experimental study support many protective training effects, i.e., improved contractility, improved resting heart rate, and increased physical work capacity and exercise tolerance. Physical training in the form of anaerobic running induces greater heart preconditioning for reperfusion injury in comparison with anaerobic swimming training. © 2023 by the authors.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback